TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 131 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $66,000 | -73.6% | 140,817 | -24.8% | 0.00% | – |
| Q1 2019 | $250,000 | -78.7% | 187,222 | -82.0% | 0.00% | -100.0% |
| Q4 2018 | $1,174,000 | +84.0% | 1,040,447 | +348.8% | 0.00% | – |
| Q3 2018 | $638,000 | -29.0% | 231,808 | -8.0% | 0.00% | – |
| Q2 2018 | $899,000 | -36.0% | 252,097 | -44.9% | 0.00% | -100.0% |
| Q1 2018 | $1,405,000 | +0.8% | 457,894 | +106.8% | 0.00% | 0.0% |
| Q4 2017 | $1,394,000 | +148.0% | 221,425 | +168.6% | 0.00% | – |
| Q3 2017 | $562,000 | -37.6% | 82,429 | -34.8% | 0.00% | -100.0% |
| Q2 2017 | $900,000 | -45.5% | 126,422 | -29.8% | 0.00% | 0.0% |
| Q1 2017 | $1,652,000 | +58.8% | 179,964 | -30.4% | 0.00% | 0.0% |
| Q4 2016 | $1,040,000 | -22.0% | 258,670 | -25.8% | 0.00% | 0.0% |
| Q3 2016 | $1,333,000 | -1.8% | 348,433 | +10.2% | 0.00% | 0.0% |
| Q2 2016 | $1,358,000 | -10.5% | 316,061 | -3.8% | 0.00% | 0.0% |
| Q1 2016 | $1,518,000 | +28.0% | 328,468 | +176.9% | 0.00% | 0.0% |
| Q4 2015 | $1,186,000 | +167.1% | 118,606 | +98.3% | 0.00% | – |
| Q3 2015 | $444,000 | -78.1% | 59,801 | +40.0% | 0.00% | -100.0% |
| Q2 2015 | $2,025,000 | -2.6% | 42,722 | -24.7% | 0.00% | 0.0% |
| Q1 2015 | $2,079,000 | +531.9% | 56,765 | +584.1% | 0.00% | – |
| Q4 2014 | $329,000 | -77.7% | 8,298 | -88.8% | 0.00% | -100.0% |
| Q3 2014 | $1,478,000 | +28.4% | 74,173 | -13.1% | 0.00% | 0.0% |
| Q2 2014 | $1,151,000 | +1727.0% | 85,390 | +1357.7% | 0.00% | – |
| Q1 2014 | $63,000 | +70.3% | 5,858 | +109.4% | 0.00% | – |
| Q4 2013 | $37,000 | -76.1% | 2,797 | -79.6% | 0.00% | – |
| Q3 2013 | $155,000 | – | 13,727 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
| Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
| Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
| Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
| Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
| EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
| Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
| TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |